Menu
Back to Journals » Cancer Management and Research » Volume 10
Original Research
Is progression-free survival a more relevant endpoint than overall survival in first-line HR+/HER2− metastatic breast cancer?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,565 | Dovepress* | 11,177+ | 964 | 12,141 | |
| PubMed Central* | 1,388 | 438 | 1,826 | ||
| Totals | 12,565 | 1,402 | 13,967 | ||
| *Since 4 May 2018 | |||||
View citations on PubMed Central and Google Scholar